Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Rare Disease Report® to Cover Rare Disease Day

Rare Disease Communications
Posted on: 22 Feb 18

In recognition of Rare Disease Day on Feb. 28, Rare Disease Report®, the digital component of Rare Disease Communications®, will provide continuous coverage and the latest content starting on Feb. 26.

“As a leading resource for rare diseases, we look forward to sharing stories from our advocates and spreading awareness of these uncommon disorders,” said Michael J. Hennessy Jr., president of Michael J. Hennessy Associates Inc., parent company of Rare Disease Report®. “We look forward to informing the community by sharing educational content throughout the day.”

To raise awareness and advance clinical and scientific research for the rare disease community, Rare Disease Report®will provide research articles, powerful patient and medical interviews and infographics. In addition, all materials will be visible on Rare Disease Report®’s social media platforms, Facebook and Twitter.

Rare Disease Day serves as a platform for the rare disease community to increase awareness of uncommon disorders through education and to propel research for treatment options. Although there are an estimated 7,000 rare diseases, which impact approximately 25 million individuals, “rare disease” is any disease that generates fewer than 200,000 cases in a particular rare disease group. Delayed diagnoses are also common, as symptoms heavily vary in comparison to a common disease.

To stay up-to-date on all rare disease coverage, visit

About Rare Disease Communications®

Rare Disease Communications® is a health care communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients can receive the correct diagnosis and be treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates Inc., family of businesses, based in Cranbury, New Jersey. MJH Associates Inc. is dedicated to improving quality of life through health care education, research and communication. To learn more, visit

View source version on

Business Wire

Last updated on: 22/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.